The Urologic Oncology Fellowship at Cleveland Clinic is a two year, SUO accredited program, designed to train the future leaders in the field of urology and urologic oncology. Cleveland Clinic’s storied urology program is considered one of the best in the world and is recognized as a leader in innovation, patient care, education and practice changing research. The urologic oncology program has long been central to that success and we hope you consider applying and helping us continue forward in this 100+ year tradition.

The first year is dedicated to gaining the tools to become both an independent and team-based researcher. There are a variety of research and educational opportunities that motivated fellows can utilize to launch a successful academic career. Through the Lerner Research Institute, the GU Malignancies Research Center, Department of Quantitative Health Sciences, Artificial Intelligence in Health Imaging Center, Clinical Researchers within GUKI or Collaborators at Case Western University, there is a dizzying array of research opportunities available. 

In addition, it is recommended that fellows take advantage of this time to expand your research and biostatistics skills. There are a variety of educational opportunities ranging from journal clubs, seminars and coursework to a Master of Science and Clinical Research at Case Western.

In the second year, oncology fellows have an unparalleled opportunity to refine surgical skills in a high volume, comprehensive surgical year. Graduating fellows will be trained to tackle even the most complex urologic oncology cases, from IVC tumor thrombectomies, Neobladders, salvage surgery, multivisceral tumors and post chemo RPLNDs to bread-and-butter cases like nephrectomies, partial nephrectomies and radical prostatectomies. Graduating fellows will also be proficient in transperinal biopsy and various focal therapy treatment options for prostate cancer. We focus on a multidisciplinary treatment of patients who have a malignancy, and deploy the range of surgical methods to do so, i.e. endoscopy, image guided surgery, laparoscopy, robotic surgery (including single port) and open surgery. Fellows function as junior faculty members with a tremendous amount of autonomy. 

Formal educational sessions include a weekly didactic lecture series that covers all areas of genitourinary oncology, multidisciplinary genitourinary oncology tumor board, focal therapy tumor boards monthly genitourinary oncology grand rounds and regular oncology journal club.

This fellowship is recognized by the Society of Urologic Oncology (SUO) and fellows are eligible to apply for membership in the SUO upon completion of the fellowship program.

Regularly performed procedures

Kidney cancer

  • Robotic, open and laparoscopic partial nephrectomy 
  • Robotic, open and laparoscopic radical nephrectomy (including IVC Tumor Thrombectomy) 
  • Robotic, open and laparoscopic nephroureterectomy

Prostate cancer

  • Robotic radical prostatectomy (including single port)
  • High Frequency Ultrasound of the prostate, Nanoknife (Electroporation) 
  • Brachytherapy
  • Transperinal Biopsy

Bladder cancer

  • Robotic and open radical cystectomy
  • Continent and non-continent urinary diversion, both open and robotic 

Testicular cancer

  • Primary and post-chemotherapy
  • Retroperitoneal lymph node dissection, both open and robotic

Fellowship faculty


Medical Oncology

Radiation Oncology



Lerner Research Institute

Quantitative Health Services

AI in Medical and Health Imaging (AIM-HI) Lab

  • Nicholas Heller, PhD

How to apply

This program participates in the Society of Urologic Oncology MATCH Program.

Contact information

For any further questions or details, please contact the Urology Fellowship Coordinator at

Cleveland Clinic Glickman Urological & Kidney Institute
9500 Euclid Ave., Q10-1
Cleveland, OH 44195

Diversity & Inclusion

Discover the role diversity and inclusion plays at Cleveland Clinic and at its Graduate Medical Education program, as well as our diversity and inclusion efforts.

Learn more